跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ONDANSETRON KABI SOLUTION FOR INJECTION 2MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
ONDANSETRON KABI SOLUTION FOR INJECTION 2MG/ML
Approved
THERAPEUTIC
ONDANSETRON KABI SOLUTION FOR INJECTION 2MG/ML
Labesfal- Laboratorios Almiro, S.A.
🇸🇬 Health Sciences Authority
Approval Date
Apr 28, 2016
Approval ID
1d3b41e767bd9677
Company
Labesfal- Laboratorios Almiro, S.A.
Type
Therapeutic
Approval Details
Approval Id
1d3b41e767bd9677
Drug Name
ONDANSETRON KABI SOLUTION FOR INJECTION 2MG/ML
Product Name
ONDANSETRON KABI SOLUTION FOR INJECTION 2MG/ML
Approval Number
SIN14994P
Approval Date
2016-04-28
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
A04AA01
Atc Item Name
ondansetron
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Company Detail Path
/organization/fresenius-kabi-singapore-pte-ltd
Active Ingredients
ondansetron hydrochloride dihydrate 2.50 mg equivalent to ondansetron
2mg/ ml
ONDANSETRON HYDROCHLORIDE DIHYDRATE 2.5 MG EQUIVALENT TO ONDANSETRON
2 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 28, 2016
Approval ID
1d3b41e767bd9677
Type
Therapeutic
Back to HSA Approvals
